3

             U.S. SECURITIES AND EXCHANGE COMMISSION
                     Washington, D.C. 20549
                                
                          FORM 10-QSB/A
                                
                         AMENDMENT NO. 1
                                
                                
         QUARTERLY REPORT UNDER SECTION 13 OR 15 (d) OF
             THE SECURITIES AND EXCHANGE ACT OF 1934
                                
          For the quarterly period ended June 30, 1995
                                
Commission file number 1-12178

                          InnoVet, Inc.
                                
(Exact name of small business issuer as specified in its charter)
                                
                                
           Florida
 (State or other jurisdiction
              of
incorporation or organization)
               
    14255 US 1, Suite 206
     Juno Beach, Florida
    (Address of principal
      executive offices)
               
          59-2699441
       (I.R.S. Employer
     Identification No.)
               
               
               
            33408
          (Zip Code)
               
                                
                         (407) 626-6025
        (Issuer's telephone number, including area code)
                                


Check  whether the issuer (1) filed all reports to  be  filed  by
Section 13 or 15(d) of the Exchange Act during the past 12 months
(or  for such shorter period that the registrant was required  to
file  such  reports),  and (2) has been subject  to  such  filing
requirements for the past 90 days.
Yes     X     No _____


State  the  number of shares outstanding of each of the  issuer's
classes  of  common  equity, as of  the latest practicable  date:
Common Stock, $0.001 Par Value; 18,656,881 shares outstanding  as
of August 7, 1995.
                              INDEX
                                
                          INNOVET, INC.
                                
PART II.  OTHER INFORMATION
Page

                        Item 6.  Exhibits
                                2

        (a)  This Amendment No. 1 reports the Financial Data
Schedule as required by
               Item 601(c) of Regulation S-B.   The Form 10-QSB
to which this Schedule
               pertains was filed on August 9, 1995.


 SIGNATURES                                                   3
                            SIGNATURE

Pursuant to the requirements of  the Securities Exchange Act of
1934, the registrant has duly caused this report to be signed on
its behalf by the undersigned thereunto duly authorized.

                              InnoVet, Inc.
                              (Registrant)



                                                                 


                              /s/SCOTT P. CIELEWICH

Date:  August 10, 1995        Scott P. Cielewich, Executive Vice
President and
                              Chief Financial Officer



<TABLE> <S> <C>

<ARTICLE> 5
<MULTIPLIER>1
       
<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          DEC-31-1995
<PERIOD-END>                               JUN-30-1995
<CASH>                                          81,677
<SECURITIES>                                         0
<RECEIVABLES>                                        0
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                               173,479
<PP&E>                                          41,279
<DEPRECIATION>                                 (32,596)
<TOTAL-ASSETS>                                 315,339
<CURRENT-LIABILITIES>                          302,446
<BONDS>                                              0
<COMMON>                                        18,657
                                0
                                          0
<OTHER-SE>                                     (5,764)
<TOTAL-LIABILITY-AND-EQUITY>                   315,339
<SALES>                                        208,803
<TOTAL-REVENUES>                               217,404
<CGS>                                          120,966
<TOTAL-COSTS>                                        0
<OTHER-EXPENSES>                               302,127
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                              40,625
<INCOME-PRETAX>                              (246,314)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                          (246,314)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                 (246,314)
<EPS-PRIMARY>                                   (0.01)
<EPS-DILUTED>                                   (0.01)
        

</TABLE>



© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission